Recently, several independent omics analyses identified ISG20L2 as a prognostic marker in different human cancers, including hepatocellular carcinoma (22–24), lung adenocarcinoma (25), and breast cancer (26). This evidence concerns the gene ISG20L2 and hepatocellular carcinoma.